Filling the need for trusted information on national health issues…

Tuberculosis

  • Your Selections:

Refine Results

date

Tags

WHO Suspends Approval Of TB Products From India’s Svizera Labs, Supplier Of Generic Drugs To 70 Nations

International Business Times: WHO Suspends Tuberculosis Drugs From Major Indian Supplier “The World Health Organization (WHO) reportedly suspended its approval of all tuberculosis products made at India’s Svizera Labs citing unreliable manufacturing standards and quality management. The company is one of the largest suppliers of generic TB medicines to more…

As Liberia’s Ebola Crisis Ends, Cases Of TB, Other Infectious Diseases Rise

STAT News: As Ebola wanes, a spike in infectious diseases sweeps through Liberia “The Ebola crisis here may be over, but its impact can be seen at health clinics across the country. Running water is sporadic. Drugs are in short supply. And with the medical system still reeling, Liberia is…

Lancet Pieces Discuss Developments In TB Diagnostics, Treatments, Policies

The Lancet: Unite to end tuberculosis Editorial Board “March 24 marks World TB Day. This year, the theme is ‘Unite to end tuberculosis.’ WHO calls on governments, civil society, and the private sector to unite to end the tuberculosis epidemic — a much-needed approach to tackle this deadliest of diseases.…

USAID Administrator Discusses Administration’s TB Budget In U.S. House; Advocates Worry Funding Cuts Could Harm Global Progress Against Disease

Center for Global Health Policy’s “Science Speaks”: With TB now No. 1 global infectious disease killer, USAID justifies cuts to global TB funding Rabita Aziz, policy research coordinator for the Center for Global Health Policy, reports on a House Appropriations State and Foreign Operations Subcommittee hearing where USAID Administrator Gayle…

Targeted Investments In Health Systems Would Lead To Greater Global Health Gains

Project Syndicate: The Right Targets for Global Health Investment Bjørn Lomborg, visiting professor at the Copenhagen Business School and director of the Copenhagen Consensus Center “…[T]rying to improve health systems uniformly, across the board, shouldn’t be our absolute top priority. But strengthening developing countries’ capacity to identify and manage known…

Blog Post Provides Roundup Of Recent Global Health Research News

Global Health Technologies Coalition’s “Breakthroughs”: Research Roundup: antibiotic resistance in preemies, a low-cost TB test, and more Kat Kelley, GHTC’s senior program assistant, highlights recent news in global health research, including a study on antibiotic-resistant bacteria in the gastrointestinal tracts of premature infants; a study on the impact of a…

Using Low-Cost TB Urine Test Among HIV Patients Could Save Lives, Research Shows

Thomson Reuters Foundation: Low-cost TB test for HIV patients can save thousands of lives: researcher “A low-cost urine test that detects tuberculosis in people living with HIV can save thousands of lives, many of them in sub-Saharan Africa, a Cape Town University researcher said on Wednesday. Nearly 40 percent of…

South Korea Considering Exceptions To North Korea Sanctions To Allow TB Medication Shipments

Reuters: South Korea considers approval of North Korea tuberculosis aid despite sanctions “South Korea is considering allowing a shipment of tuberculosis medication to North Korea, a government official said on Thursday, despite newly imposed sanctions against the reclusive state for its recent nuclear test and rocket launch…” (Park/Pearson, 3/10).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.